Merck backs GNS Healthcare

GNS Healthcare, a precision medicine AI company, has extended its Series D funding round, bringing the amount raised to $28 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this